Cargando…

Effect of fenfluramine on convulsive seizures in CDKL5 deficiency disorder

CDKL5 deficiency disorder (CDD) is an X‐linked pharmacoresistant neurogenetic disorder characterized by global developmental delays and uncontrolled seizures. Fenfluramine (FFA), an antiseizure medication (ASM) indicated for treating convulsive seizures in Dravet syndrome, was assessed in six patien...

Descripción completa

Detalles Bibliográficos
Autores principales:	Devinsky, Orrin, King, LaToya, Schwartz, Danielle, Conway, Erin, Price, Dana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Brief Communications
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8360137/ https://www.ncbi.nlm.nih.gov/pubmed/33979451 http://dx.doi.org/10.1111/epi.16923

Ejemplares similares

Ataluren for drug‐resistant epilepsy in nonsense variant‐mediated Dravet syndrome and CDKL5 deficiency disorder
por: Devinsky, Orrin, et al.
Publicado: (2021)

Fenfluramine significantly reduces day‐to‐day seizure burden by increasing number of seizure‐free days and time between seizures in patients with Dravet syndrome: A time‐to‐event analysis
por: Sullivan, Joseph, et al.
Publicado: (2021)

International Consensus Recommendations for the Assessment and Management of Individuals With CDKL5 Deficiency Disorder
por: Amin, Sam, et al.
Publicado: (2022)

Fenfluramine: New Treatment for Seizures in Dravet Syndrome
por: Pierce, Joanna Garcia, et al.
Publicado: (2020)

Complex CDKL5 translational regulation and its potential role in CDKL5 deficiency disorder
por: Ruggiero, Valeria, et al.
Publicado: (2023)

Cortical Visual Impairment in CDKL5 Deficiency Disorder
por: Quintiliani, Michela, et al.
Publicado: (2022)

Novel preclinical model for CDKL5 deficiency disorder
por: Serrano, Rita J., et al.
Publicado: (2022)

Seizure Clusters: Morbidity and Mortality
por: Bauman, Kristie, et al.
Publicado: (2021)

Cdkl5 mutant zebrafish shows skeletal and neuronal alterations mimicking human CDKL5 deficiency disorder
por: Varela, Tatiana, et al.
Publicado: (2022)

Reintroducing Fenfluramine as a Treatment for Seizures: Current Knowledge, Recommendations and Gaps in Understanding
por: Dini, Gianluca, et al.
Publicado: (2023)

Convulsive Seizures
por: Kahn, Eugen
Publicado: (1943)

CDKL5 Deficiency Disorder—A Complex Epileptic Encephalopathy
por: Jakimiec, Martyna, et al.
Publicado: (2020)

Electrophysiological biomarkers of brain function in CDKL5 deficiency disorder
por: Saby, Joni N, et al.
Publicado: (2022)

CDKL5 Deficiency Disorder (CDD)—Rare Presentation in Male
por: Rodak, Małgorzata, et al.
Publicado: (2022)

Ganaxolone: A New Treatment for CDKL5 Deficiency Disorder
por: Vossler, David G.
Publicado: (2022)

Cyclin-Dependent Kinase-Like 5 (CDKL5): Possible Cellular Signalling Targets and Involvement in CDKL5 Deficiency Disorder
por: Katayama, Syouichi, et al.
Publicado: (2020)

Phenotypic characterization of Cdkl5-knockdown neurons establishes elongated cilia as a functional assay for CDKL5 Deficiency Disorder
por: Di Nardo, Alessia, et al.
Publicado: (2022)

Expression of a Secretable, Cell-Penetrating CDKL5 Protein Enhances the Efficacy of Gene Therapy for CDKL5 Deficiency Disorder
por: Medici, Giorgio, et al.
Publicado: (2022)

SUDEP in patients with epilepsy and nonepileptic seizures
por: Verducci, Chloe, et al.
Publicado: (2019)

Fenfluramine: a plethora of mechanisms?
por: Sourbron, Jo, et al.
Publicado: (2023)

Rett Syndrome and CDKL5 Deficiency Disorder: From Bench to Clinic
por: Kadam, Shilpa D., et al.
Publicado: (2019)

Current neurologic treatment and emerging therapies in CDKL5 deficiency disorder
por: Olson, Heather E., et al.
Publicado: (2021)

Pharmacological Characterization of an Antisense Knockdown Zebrafish Model of Dravet Syndrome: Inhibition of Epileptic Seizures by the Serotonin Agonist Fenfluramine
por: Zhang, Yifan, et al.
Publicado: (2015)

Reigning in Excitatory Signaling in CDKL5 Deficiency
por: Forcelli, Patrick A.
Publicado: (2019)

Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder
por: Wong, Kingsley, et al.
Publicado: (2022)

CDKL5 deficiency disorder: progressive brain atrophy may be part of the syndrome
por: Specchio, Nicola, et al.
Publicado: (2023)

Efficacy and Safety of Fenfluramine for the Treatment of Seizures Associated With Lennox-Gastaut Syndrome: A Randomized Clinical Trial
por: Knupp, Kelly G., et al.
Publicado: (2022)

Effect of fenfluramine on seizures and comorbidities in SCN8A‐developmental and epileptic encephalopathy: A case series
por: Aledo‐Serrano, Ángel, et al.
Publicado: (2022)

Mutation in an alternative transcript of CDKL5 in a boy with early-onset seizures
por: Bodian, Dale L., et al.
Publicado: (2018)

Heterozygous CDKL5 Knockout Female Mice Are a Valuable Animal Model for CDKL5 Disorder
por: Fuchs, Claudia, et al.
Publicado: (2018)

Searching for biomarkers of CDKL5 disorder: early-onset visual impairment in CDKL5 mutant mice
por: Mazziotti, Raffaele, et al.
Publicado: (2017)

Seizure‐related deaths in children: The expanding spectrum
por: Harowitz, Jenna, et al.
Publicado: (2021)

Microtubules: A Key to Understand and Correct Neuronal Defects in CDKL5 Deficiency Disorder?
por: Barbiero, Isabella, et al.
Publicado: (2019)

Correction to: Factors influencing the attainment of major motor milestones in CDKL5 deficiency disorder
por: Wong, Kingsley, et al.
Publicado: (2022)

Cardiac Functional and Structural Abnormalities in a Mouse Model of CDKL5 Deficiency Disorder
por: Loi, Manuela, et al.
Publicado: (2023)

Species‐specific susceptibility to cannabis‐induced convulsions
por: Whalley, Benjamin J, et al.
Publicado: (2018)

Prevalence and mortality of epilepsies with convulsive and non-convulsive seizures in Kilifi, Kenya
por: Kariuki, Symon M, et al.
Publicado: (2021)

Fenfluramine in the treatment of hypertensive patients with refractory obesity.
por: Scott, M. E., et al.
Publicado: (1975)

Improving Therapy of Pharmacoresistant Epilepsies: The Role of Fenfluramine
por: Dini, Gianluca, et al.
Publicado: (2022)

Novel CDKL5 mutations were found in patients in China: retrospective investigation in cases of CDKL5-related disorders
por: Yan, Yumei, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_l1s8fpkhqn8q7nhog231psra9b